Spotlight Therapeutics Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Spotlight Therapeutics is a Hayward, California-based biotechnology research company founded in December 2017 by Alex Marson, Jacob Corn, and Patrick Hsu. It seeks to develop a new class of therapeutics by enabling direct in vivo gene editing, aiming for precise edits in targeted cell populations within living organisms. The company’s oncology program focuses on modifying genes in disease-relevant organs to inactivate or alter the gene product. 

Its preclinical research spans areas such as protein engineering, gene editing, immuno-oncology, and in vivo safety studies as it expands its development efforts. Recent reporting notes the firm is pursuing precision in vivo platforms to deliver gene editing tools to hard-to-reach tissues, with potential relevance for neurology and immunology.

Sign up for free to view info

Company overview Employee directory